英語論文を38本追加しました
- サイト管理者
- 2024年9月28日
- 読了時間: 3分
2024年8月30日検索分の7本、9月6日検索分の8本、9月13日検索分の10本、9月20日検索分の4本、9月27日検索分の9本の合計38本を追加しました。
日本の先生方の論文は5本です。
The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot study |
Novel tau filament folds in individuals with MAPT mutations P301L and P301T |
The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy |
An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration |
Systematic review of phenotypes in McLeod syndrome and case report of a progressive supranuclear palsy in a female carrier |
Clinical Practices and Opinions toward Gastrostomy Use in Patients with Atypical Parkinsonian Syndromes: A National Survey in the UK |
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement |
Cerebrospinal Fluid Total and Phosphorylated Tau Protein in Behavioral Variant Frontotemporal Dementia, Progressive Supranuclear Palsy, Corticobasal Syndrome and Non-Fluent Agrammatic Primary Progressive Aphasia: A Systematic Review and Meta-Analysis |
Impact of the Anticholinergic Burden on Disease-Specific Symptoms in Parkinsonian Syndromes |
Relationships between regional burden of tau pathology and age at death and disease duration in PSP |
Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory |
Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features |
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy |
CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders |
Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe |
Long-standing preservation of levodopa response in progressive supranuclear palsy |
Clinical characteristics of Japanese patients with corticobasal degeneration |
Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo(31)P-MRS studies |
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes |
Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer's disease tau seeds have distinct properties |
Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics |
GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate |
The value of PET/CT in the diagnosis and differential diagnosis of Parkinson's disease: a dual-tracer study |
Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies |
Proteolysis of tau by granzyme A in tauopathies generates fragments that are aggregation prone |
Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function |
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy |
Low-dose lamotrigine induces Pisa syndrome in a patient with probable corticobasal degeneration despite previous use |
A human Tau expressing zebrafish model of progressive supranuclear palsy identifies Brd4 as a regulator of microglial synaptic elimination |
Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response |
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review |
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome |
Abnormal Structural-Functional Coupling and MRI Alterations of Brain Network Topology in Progressive Supranuclear Palsy |
Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson's disease |
Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy |
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials |
A case of corticobasal syndrome possibly associated with anti-Yo antibodies |
Dynamic aphasia as an early sign of corticobasal degeneration: Clinico-radio-pathological correlation |
コメント